News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BG Medicine Sees IPO of 4.5 Million Shares at $14-$16/shr


11/13/2007 6:47:13 AM

Nov 13 (Reuters) - BG Medicine Inc registerd its initial public offering of 4.5 million shares at an estimated price of $14 to $16 per share. The Waltham, Massachusetts-based molecular diagnostics company said in a filing with the U.S. Securities and Exchange Commission that Cowen & Co and Leerink Swann were underwriting the IPO.

Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES